Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hepatology
•
Transplant Hepatology
Having gone through multiple iterations, what MELD updates/considerations should we anticipate in the future?
Related Questions
How would you workup a patient who develops ascites AFTER liver transplantation?
With an increase in the prevalence of MASLD in the United States population, what recipient and donor characteristics do you find favorable for acceptance of a highly steatotic graft?
What would be the right patient profile and experience for someone who may have (operational) tolerance and how do you approach immunosuppresison management (or withdrawal) in this patient?
Should a patient who requires definitive treatment for prostate cancer as a pre-transplant requirement be strictly required to complete their course prior to transplant/initiation of immunosuppression?
How do you determine when you would treat an identified spleno-renal shunt and how?
How much do you factor in a patient's frailty in selection for transplant if the underlying driver for their debility is their underlying liver disease itself?
For cirrhotic patients that we take care of in the community, when should be the optimal timing of referral for liver transplantation aside from the MELD score?
Are there any specific guidelines for the transplantation of metastatic disease to the liver or are these institution specific? In general, for which malignancy would this most commonly be entertained and what patient criteria would make them an optimal candidate?
For how long would you treat a patient with latent TB before allowing them to proceed with a liver transplant?
What cardiac testing do you perform for patients undergoing liver transplant evaluation?
